Avoro Capital Advisors LLC Alnylam Pharmaceuticals, Inc. Transaction History

Avoro Capital Advisors LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$143.31 - $247.0 $14.3 Million - $24.7 Million	100,000 Added 33.33%	400,000 $97.2 Million
Q1 2024 May 15, 2024	SELL	$146.51 - $198.2 $119 Million - $161 Million	-811,111 Reduced 73.0%	300,000 $44.8 Million
Q4 2023 Feb 14, 2024	BUY	$151.41 - $196.57 $15.1 Million - $19.7 Million	100,000 Added 9.89%	1,111,111 $213 Million
Q3 2023 Nov 14, 2023	SELL	$170.77 - $211.65 $16 Million - $19.9 Million	-93,889 Reduced 8.5%	1,011,111 $179 Million
Q3 2022 Nov 14, 2022	SELL	$138.54 - $232.0 $35.3 Million - $59.2 Million	-255,000 Reduced 18.75%	1,105,000 $221 Million
Q2 2022 Aug 15, 2022	BUY	$120.42 - $169.29 $7.23 Million - $10.2 Million	60,000 Added 4.62%	1,360,000 $198 Million
Q1 2022 May 16, 2022	BUY	$127.18 - $173.91 $28.6 Million - $39.1 Million	225,000 Added 20.93%	1,300,000 $212 Million
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $35.9 Million - $47.1 Million	225,000 Added 26.47%	1,075,000 $182 Million
Q3 2021 Nov 15, 2021	SELL	$169.75 - $207.73 $25.5 Million - $31.2 Million	-150,000 Reduced 15.0%	850,000 $160 Million
Q2 2021 Aug 16, 2021	BUY	$128.63 - $176.89 $129 Million - $177 Million	1,000,000 New	1,000,000 $170 Million
Q3 2018 Nov 14, 2018	SELL	$87.52 - $122.67 $61.3 Million - $85.9 Million	-700,100 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$88.31 - $107.8 $61.8 Million - $75.5 Million	700,100 New	700,100 $69 Million

644

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Avoro Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Avoro Capital Advisors LLC with notifications on news.